Skip to content
#protein folding Open access

HNF-4α regulates hepatoma cell growth and apoptosis through the IGFBP-2/Notch1 signaling pathway

Sep 2026 · Pakistan Journal of Pharmaceutical Sciences · 0 citations · 28 references
Growth Hormone and Insulin-like Growth Factors

TL;DR

HNF-4α inhibits HCC cell proliferation and invasion and promotes apoptosis through negative regulation of the IGFBP-2/Notch1 signaling pathway, providing new experimental evidence for the tumor-suppressive mechanism of HNF-4α in HCC.

Abstract

Abstract: Background: Hepatocyte nuclear factor 4α (HNF-4α) is a liver-enriched transcription factor that is downregulated in hepatocellular carcinoma (HCC). However, the molecular mechanisms by which it regulates the malignant phenotype of HCC cells remain unclear. Objectives: To investigate whether HNF-4α affects HCC cell proliferation, invasion and apoptosis by regulating the IGFBP-2/Notch1 signaling pathway. Methods: HNF-4α was overexpressed and silenced in HepG2 cells using a pcDNA3.1-HNF-4α plasmid and HNF-4α-specific siRNA, respectively. RT-qPCR and Western blotting verified transfection efficiency. Cell proliferation and invasion were assessed by MTT and Transwell assays, respectively. Apoptosis was evaluated by Caspase 3 activity assay. IGFBP-2 secretion was measured by ELISA. Protein expression of Bcl-2, Bax, IGFBP-2 and Notch1 was detected by Western blotting. Results: HNF-4α overexpression significantly inhibited HepG2 cell proliferation (by approximately 35% at 48 h and 45% at 72 h) and invasion (by approximately 55%), while markedly increasing Caspase 3 activity (approximately 2.8-fold) and the Bax/Bcl-2 ratio (from 0.42 to 2.18). Moreover, HNF-4α overexpression significantly suppressed IGFBP-2 secretion (by approximately 60%) and downregulated IGFBP-2 (by approximately 55%) and Notch1 NICD (by approximately 50%) protein expression (all P < 0.001). Conversely, HNF-4α knockdown produced opposite effects, significantly promoting proliferation (by approximately 40% at 48 h and 55% at 72 h) and invasion (by approximately 70%), decreasing Caspase 3 activity (by approximately 55%) and the Bax/Bcl-2 ratio (from 0.45 to 0.19) and upregulating IGFBP-2 (approximately 2.2-fold) and Notch1 NICD (approximately 1.8-fold) expression (all P < 0.01). Conclusion: HNF-4α inhibits HCC cell proliferation and invasion and promotes apoptosis through negative regulation of the IGFBP-2/Notch1 signaling pathway, providing new experimental evidence for the tumor-suppressive mechanism of HNF-4α in HCC.

Read PDF

Similar papers

Sep 2026

HnRNPA1-Regulated miR-23a-3p Promotes Hepatocellular Carcinoma Metastasis by Targeting the PTEN Signaling Pathway.

INTRODUCTION Hepatocellular carcinoma (HCC) accounts for 75-85% of primary liver cancer cases and remains a major cause of cancer-related mortality worldwide. Despite its high incidence, there is currently no definitive cure for most patients, and the underlying molecular mechanisms are not fully understood. METHODS...

Wei-Wei Wang, Sen Lu, Feng Jiao et al. · 0 citations
Open access Sep 2026

Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling

Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated mortality worldwide, and current targeted therapeutic options remain inadequate. Gilteritinib, a clinically approved tyrosine kinase inhibitor, has shown antitumor activity in hematologic malignancies; however, its therapeutic...

Si-Jing Chen, Yun-Yang Zhao, Yun-Qi Pan et al. · 0 citations
Oct 2026

METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression.

Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.

Meng-Ke Li, Yan Zhao, Yuan Li · 0 citations
Oct 2026

LGR4 interacts with RhoA to modulate cell survival and epithelial-mesenchymal transition via the Wnt/β-catenin pathway in benign prostatic hyperplasia.

It is demonstrated that LGR4 was overexpressed in BPH and localized within the stromal and epithelial components of prostate and regulated the Wnt/β-catenin pathway by interacting with RhoA to control cellular proliferation, apoptosis and EMT, while barely affected cell cycle.

Ji-Zhang Qiu, Huan Liu, Xiao-Long Ma et al. · 0 citations
Open access Oct 2026

Importazole suppresses proliferation and modulates KPNB1 and Bax/Bcl-2 expression in HepG2 hepatocellular carcinoma cells: bioinformatic, in vitro, and in ovo analyses

Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and is associated with limited therapeutic options and poor prognosis at advanced stages. Although aberrant activation of importin-β-dependent nuclear transport has been reported in several malignancies, the clinical and therapeutic...

Kübra Sena Baş Topcu · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.